CU20070072A7 - USE OF [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE FOR THE TREATMENT OF INFECTION WITH HEPATITIS C AND PHARMACEUTICAL COMPOSITION INCLUDING [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE - Google Patents

USE OF [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE FOR THE TREATMENT OF INFECTION WITH HEPATITIS C AND PHARMACEUTICAL COMPOSITION INCLUDING [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE

Info

Publication number
CU20070072A7
CU20070072A7 CU20070072A CU20070072A CU20070072A7 CU 20070072 A7 CU20070072 A7 CU 20070072A7 CU 20070072 A CU20070072 A CU 20070072A CU 20070072 A CU20070072 A CU 20070072A CU 20070072 A7 CU20070072 A7 CU 20070072A7
Authority
CU
Cuba
Prior art keywords
cyclosporine
etval
meala
treatment
infection
Prior art date
Application number
CU20070072A
Other languages
Spanish (es)
Inventor
Rolland-Yves Mauvernay
Gregoire Vuagniaux
Jean-Maurice Dumont
Pietro Scalfaro
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Priority to CU20070072A priority Critical patent/CU20070072A7/en
Publication of CU20070072A7 publication Critical patent/CU20070072A7/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere al uso en el tratamiento de infección por HCV, ya sea como agentes activos simples o en combinación con otro agente activo, de una ciclosporina que tiene actividad de enlace incrementando a ciclofilina y esencialmente carece de actividad inmunosupresora.This invention relates to the use in the treatment of HCV infection, either as simple active agents or in combination with another active agent, of a cyclosporine that has binding activity increasing to cyclophilin and essentially lacks immunosuppressive activity.

CU20070072A 2007-04-02 2007-04-02 USE OF [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE FOR THE TREATMENT OF INFECTION WITH HEPATITIS C AND PHARMACEUTICAL COMPOSITION INCLUDING [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE CU20070072A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20070072A CU20070072A7 (en) 2007-04-02 2007-04-02 USE OF [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE FOR THE TREATMENT OF INFECTION WITH HEPATITIS C AND PHARMACEUTICAL COMPOSITION INCLUDING [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20070072A CU20070072A7 (en) 2007-04-02 2007-04-02 USE OF [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE FOR THE TREATMENT OF INFECTION WITH HEPATITIS C AND PHARMACEUTICAL COMPOSITION INCLUDING [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE

Publications (1)

Publication Number Publication Date
CU20070072A7 true CU20070072A7 (en) 2009-09-08

Family

ID=44280821

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20070072A CU20070072A7 (en) 2007-04-02 2007-04-02 USE OF [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE FOR THE TREATMENT OF INFECTION WITH HEPATITIS C AND PHARMACEUTICAL COMPOSITION INCLUDING [D-MEALA] 3- [ETVAL] 4-CYCLOSPORINE

Country Status (1)

Country Link
CU (1) CU20070072A7 (en)

Similar Documents

Publication Publication Date Title
BRPI0515494A (en) use of [d-meala] 3- [etval] 4-cyclosporine for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala] 3- [etval] 4-cyclosporine
MX2010002247A (en) USE OF A COMBINATION OF HESPERIDINE AND A MICROORGANISM TO INFLUATE THE FUNCTION OF SKIN BARRIER.
AR054227A1 (en) COMPOSITION OF ACTIVE PRINCIPLES
CR20140539A (en) PREPARATION CONTAINING AT LEAST A CONAZOLIC FUNGICIDE
UY29086A1 (en) NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS.
ATE551077T1 (en) REDUCING INFECTION RELATED TO A MEDICAL DEVICE
UY33984A (en) USE OF 2,3-DIHYDROIMIDAZO [1,2-C] SUBSTITUTED KINAZOLINS
CR11167A (en) USE OF HOMO AND COPOLIMEROS FOR THE STABILIZATION OF FORMULATIONS OF ACTIVE PRINCIPLES
CL2012001080A1 (en) Rifaximin solid dispersion and a pharmaceutically acceptable carrier; pharmaceutical composition; use in the treatment and / or prevention of a microbial infection comprising the administration of the solid dispersion.
CR8428A (en) ENDOPARASITICID AGENT FOR TOPICAL ADMINISTRATION
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
NI201000044A (en) BUPROPION BROMHYDRATE AND THERAPEUTIC APPLICATIONS
CL2011002700A1 (en) Highly reliable ingestible event marker and method for its use.
BRPI0915589B8 (en) synergistic herbicidal combination of clomazone and petoxamide
AR072685A1 (en) TOPICAL COMPOSITION FOR THE TREATMENT OF ACTINIC KERATOSIS
MX2011007195A (en) Cyclosporine derivative for use in the treatment of hcv and hiv infection.
EA201200484A1 (en) PHARMACEUTICAL COMPOSITION WITH EXISTING SUBSTANCES - METHORMIN AND SYTAGLIPTIN OR VILDAGLIPTIN
NI200800176A (en) USE OF BENZO-FUSED HETEROCYCLIC SULFAMID DERIVATIVES FOR THE TREATMENT OF DEPRESSION
AR059097A1 (en) LONG-TERM TREATMENT OF HIV INFECTION
CL2007003587A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE TO TREAT OR PREVENT INFECTION OF HEPATITIS C.
BR112013014189A8 (en) pharmaceutical composition, use of a potentiating agent and use of a composition
AR082155A1 (en) ANTISEPTIC AND DISINFECTANT FORMULATION THAT HAS REDUCED IODINE CONTENT
MX2011012143A (en) Compositions suitable for the topical treatment of fungal infections of the skin and nails.
BRPI0518869A2 (en) cytotoxic agents comprising taxanes
CL2009000665A1 (en) Pyrrolidinyl derived compounds; pharmaceutical composition comprising said compounds; and its use in the treatment of anxiety, depression or both.